CHLORAPREP WITH TINT (chlorhexidine gluconate and isopropyl alcohol) by Becton Dickinson. Approved for bacteria. First approved in 2000.
Drug data last refreshed 14h ago · AI intelligence enriched 6d ago
CHLORAPREP WITH TINT is a topical antiseptic sponge combining chlorhexidine gluconate and isopropyl alcohol, used for pre-operative skin antisepsis to reduce bacterial colonization. The product leverages the broad-spectrum antimicrobial activity of chlorhexidine paired with rapid alcohol-based disinfection for surgical site preparation.
Product faces imminent loss of exclusivity (0.9 years remaining), signaling potential downsizing of brand-specific commercial teams and shift toward generic/value-based roles.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Worked on CHLORAPREP WITH TINT at Becton Dickinson? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Patent cliff in less than a year — expect lifecycle management and generic defense hiring
CHLORAPREP WITH TINT currently supports 552 linked job openings, predominantly in manufacturing, engineering, and commercial functions, reflecting BD's established supply chain and sales infrastructure. However, roles are likely transitioning toward cost reduction, supply chain optimization, and post-LOE portfolio management rather than growth-focused activities.
552 open roles linked to this drug
Upgrade to Pro to access patent cliff timelines and LOE dates and other premium pharma intelligence.
Upgrade to Pro — $25/mo